Jeremy Grantham Medpace Holdings, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $1.28 Million - $1.46 Million	3,432 Added 9.86%	38,237 $15.7 Million
Q1 2024 May 14, 2024	SELL	$284.87 - $413.31 $4.77 Million - $6.93 Million	-16,760 Reduced 32.5%	34,805 $14.1 Million
Q4 2023 Feb 13, 2024	SELL	$227.52 - $312.68 $556,058 - $764,189	-2,444 Reduced 4.53%	51,565 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $2.02 Million - $2.43 Million	8,635 Added 19.03%	54,009 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $8.5 Million - $10.9 Million	45,374 New	45,374 $10.9 Million
Q1 2019 May 14, 2019	SELL	$49.38 - $70.58 $617,250 - $882,250	-12,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$43.25 - $63.74 $294,100 - $433,432	-6,800 Reduced 35.23%	12,500 $749,000
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $23,821 - $31,822	700 Added 3.76%	19,300 $830,000
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $595,758 - $726,330	18,600 New	18,600 $649,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.